103 related articles for article (PubMed ID: 7791356)
1. GI hormonal changes in diabetes influence pancreatic cancer growth.
Fisher WE; Boros LG; O'Dorisio TM; O'Dorisio MS; Schirmer WJ
J Surg Res; 1995 Jun; 58(6):754-8. PubMed ID: 7791356
[TBL] [Abstract][Full Text] [Related]
2. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse.
Fisher WE; Muscarella P; Boros LG; Schirmer WJ
Surgery; 1998 Mar; 123(3):315-20. PubMed ID: 9526524
[TBL] [Abstract][Full Text] [Related]
3. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
4. The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induced diabetic rat.
Howarth FC; Marzouqi FM; Al Saeedi AM; Hameed RS; Adeghate E
JOP; 2009 Sep; 10(5):485-91. PubMed ID: 19734622
[TBL] [Abstract][Full Text] [Related]
5. Effect of human growth hormone on human pancreatic carcinoma growth, protein, and cell cycle kinetics.
Harrison LE; Blumberg D; Berman R; Ng B; Hochwald S; Brennan MF; Burt M
J Surg Res; 1996 Mar; 61(2):317-22. PubMed ID: 8656602
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin and sulphonylureas on insulin-like growth factor-I levels in streptozotocin-induced diabetic rats.
Guney E; Kisakol G; Oge A; Yilmaz C; Kabalak T
Neuro Endocrinol Lett; 2002; 23(5-6):437-9. PubMed ID: 12500166
[TBL] [Abstract][Full Text] [Related]
7. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
[TBL] [Abstract][Full Text] [Related]
9. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells.
Kawaguchi M; Hosotani R; Kogire M; Ida J; Doi R; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Masui T; Imamura M
Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
13. Glucagon and insulin relationships in genetically diabetic (db/db) and in streptozotocin-induced diabetic mice.
Stearns SB; Benzo CA
Horm Metab Res; 1978 Jan; 10(1):20-3. PubMed ID: 147231
[TBL] [Abstract][Full Text] [Related]
14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
16. The influence of insulin on secretion of IGF-I and IGFBP-I in cultures of human endometrial stromal cells.
Lin J; Li R; Zhou J
Chin Med J (Engl); 2003 Feb; 116(2):301-4. PubMed ID: 12775252
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Wang Q; Brubaker PL
Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
Han HJ; Kang CW; Park SH
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
[TBL] [Abstract][Full Text] [Related]
20. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]